If you have know cardiovascular disease and are already on a statin and still have LDL above 1.8 mmol/L; please speak to your doctor. You might qualify for treatment with PCSK9 inhibitor.
Objective of Population Health Project - PCSK9 candidate
Identify high risk patients who are condidate for treatment with PCSK9.
|Population Health||Screen for HeFH population||Use report by template:|
42. LDL > 4.9 in 12 months
47. statin by provider
Statin by provider
pro-protein convertase substilisin/kexin type 9
HeFH Population; TC/LDL > 7.5/4.9 + (tendon xanthomas or FHx: MI<60 yrs of age) LDL -C >=1.8 mmol/L while on statin therapy
Lifetime burden of high cholesterol leads to huge increased risk of cardiovascular disease. FH is among the most common inherited conditions: Prevalence of heterozygous FH (HeFH) is 1:300-1:500.